allan vaag
allan vaag
Steno Diabetes Center Copenhagen
Verified email at
Cited by
Cited by
Epigenetic differences arise during the lifetime of monozygotic twins
MF Fraga, E Ballestar, MF Paz, S Ropero, F Setien, ML Ballestar, ...
Proceedings of the National Academy of Sciences 102 (30), 10604-10609, 2005
Interleukin-1–receptor antagonist in type 2 diabetes mellitus
CM Larsen, M Faulenbach, A Vaag, A Vølund, JA Ehses, B Seifert, ...
New England Journal of Medicine 356 (15), 1517-1526, 2007
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+ SU): a randomised controlled trial
D Russell-Jones, A Vaag, O Schmitz, BK Sethi, N Lalic, S Antic, ...
Diabetologia 52 (10), 2046-2055, 2009
Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance–a population-based twin study
P Poulsen, KO Kyvik, A Vaag, H Beck-Nielsen
Diabetologia 42 (2), 139-145, 1999
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million …
TK Schramm, GH Gislason, L Køber, S Rasmussen, JN Rasmussen, ...
Circulation 117 (15), 1945-1954, 2008
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction …
TK Schramm, GH Gislason, A Vaag, JN Rasmussen, F Folke, ML Hansen, ...
European heart journal 32 (15), 1900-1908, 2011
Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients
MA Gall, P Rossing, P Skøtt, P Damsbo, A Vaag, K Bech, A Dejgaard, ...
Diabetologia 34 (9), 655-661, 1991
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
B Hemmingsen, SS Lund, C Gluud, A Vaag, TP Almdal, J Wetterslev
Cochrane Database of Systematic Reviews, 2013
Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia
J Rung, S Cauchi, A Albrechtsen, L Shen, G Rocheleau, ...
Nature genetics 41 (10), 1110-1115, 2009
TXNIP regulates peripheral glucose metabolism in humans
H Parikh, E Carlsson, WA Chutkow, LE Johansson, H Storgaard, ...
PLoS medicine 4 (5), e158, 2007
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
CM Larsen, M Faulenbach, A Vaag, JA Ehses, MY Donath, ...
Diabetes care 32 (9), 1663-1668, 2009
Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
B Hemmingsen, SS Lund, C Gluud, A Vaag, T Almdal, C Hemmingsen, ...
Bmj 343, 2011
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.
A Vaag, JE Henriksen, H Beck-Nielsen
The Journal of clinical investigation 89 (3), 782-788, 1992
Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs
P Poulsen, AA Vaag, KO Kyvik, DM Jensen, H Beck-Nielsen
Diabetologia 40 (4), 439-446, 1997
Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins
C Ling, P Poulsen, E Carlsson, M Ridderstråle, P Almgren, ...
The Journal of clinical investigation 114 (10), 1518-1526, 2004
Low birthweight is associated with specific changes in muscle insulin-signalling protein expression
SE Ozanne, CB Jensen, KJ Tingey, H Storgaard, S Madsbad, AA Vaag
Diabetologia 48 (3), 547-552, 2005
Genome-wide associations for birth weight and correlations with adult disease
M Horikoshi, RN Beaumont, FR Day, NM Warrington, MN Kooijman, ...
Nature 538 (7624), 248-252, 2016
Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes
E Nilsson, PA Jansson, A Perfilyev, P Volkov, M Pedersen, MK Svensson, ...
Diabetes 63 (9), 2962-2976, 2014
Metabolic and vascular effects of tumor necrosis factor-α blockade with etanercept in obese patients with type 2 diabetes
H Dominguez, H Storgaard, C Rask-Madsen, TS Hermann, N Ihlemann, ...
Journal of vascular research 42 (6), 517-525, 2005
Genetic versus environmental aetiology of the metabolic syndrome among male and female twins
P Poulsen, A Vaag, K Kyvik, H Beck-Nielsen
Diabetologia 44 (5), 537-543, 2001
The system can't perform the operation now. Try again later.
Articles 1–20